Practice-changing updates on multiple myeloma: highlights from the 2024 ASH annual meeting
Abstract Although multiple myeloma (MM) remains an incurable disease, the advancements in patient management are rapid and novel approaches emerge each year. At the last congress of the American Society of Hematology (ASH) 2024, several practice-changing studies were presented that challenge current...
Saved in:
| Main Authors: | Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Journal of Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13045-025-01711-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01) -
Bleeding Diathesis Secondary to a Heparin-Like Anticoagulant in a Patient with Multiple Myeloma—A Case Report and Review of Literature
by: Nihar Desai, et al.
Published: (2024-02-01) -
A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
by: Alfred L. Garfall, et al.
Published: (2025-07-01) -
Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting
by: Qing Zhang, et al.
Published: (2025-07-01) -
Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)
by: Ayman Alhejazi, et al.
Published: (2025-05-01)